Inventor · disambiguated record
Stefan Limmer
Also filed as: LIMMER STEFAN
28 granted patents·13 pending applications·615 citations·filing 2002–2018
97Inventor score
Files withALNYLAM PHARMACEUTICALS INC13KREUTZER ROLAND12RIBOPHARMA AG4ALNYLAM EUROPE AG3JOHN MATTHIAS2
Top patents by PatentIndex Score
41 records- 0196US8546143B2Compositions and methods for inhibiting expression of a target geneKREUTZER ROLAND·Filed 2010·Granted Oct 1, 2013·47 cites·18 claims
- 0296US8101584B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2003·Granted Jan 24, 2012·54 cites·10 claims
- 0396US7829693B2Compositions and methods for inhibiting expression of a target geneALNYLAM PHARMACEUTICALS INC·Filed 2003·Granted Nov 9, 2010·134 cites·6 claims
- 0495US8101742B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2007·Granted Jan 24, 2012·18 cites·24 claims
- 0595US7786290B2Double-stranded ribonucleic acid with increased effectiveness in an organismALNYLAM PHARMACEUTICALS INC·Filed 2004·Granted Aug 31, 2010·99 cites·31 claims
- 0694US7348314B2Compositions and methods for inhibiting viral replicationALNYLAM EUROPE AG·Filed 2003·Granted Mar 25, 2008·45 cites·3 claims
- 0792US8114851B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2007·Granted Feb 14, 2012·10 cites·11 claims
- 0891US7196184B2Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion geneALNYLAM EUROPE AG·Filed 2003·Granted Mar 27, 2007·26 cites·2 claims
- 0990US8183362B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2007·Granted May 22, 2012·7 cites·16 claims
- 1090US8114981B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2007·Granted Feb 14, 2012·7 cites·22 claims
- 1190US7994309B2Compositions and methods for inhibiting expression of a mutant geneALNYLAM PHARMACEUTICALS INC·Filed 2010·Granted Aug 9, 2011·6 cites·32 claims
- 1289US7846907B2Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion geneALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Dec 7, 2010·5 cites·8 claims
- 1388US7473525B2Compositions and methods for inhibiting expression of anti-apoptotic genesALNYLAM EUROPE AG·Filed 2003·Granted Jan 6, 2009·53 cites·4 claims
- 1487US8202980B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2003·Granted Jun 19, 2012·14 cites·17 claims
- 1587US8168776B2Method for making a 21 nucleotide double stranded RNA chemically linked at one endKREUTZER ROLAND·Filed 2003·Granted May 1, 2012·14 cites·8 claims
- 1686US7745418B2Compositions and methods for inhibiting viral replicationALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Jun 29, 2010·4 cites·28 claims
- 1785US8877726B2Method and medicament for inhibiting the expression of a given geneALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Nov 4, 2014·3 cites·18 claims
- 1885US8273868B2Compositions and methods for inhibiting viral replicationJOHN MATTHIAS·Filed 2009·Granted Sep 25, 2012·7 cites·24 claims
- 1985US8273870B2Compositions and methods for inhibiting expression of a mutant geneKREUTZER ROLAND·Filed 2011·Granted Sep 25, 2012·6 cites·33 claims
- 2085US8119608B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2003·Granted Feb 21, 2012·11 cites·14 claims
- 2183US9133454B2Method and medicament for inhibiting the expression of a given geneALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Sep 15, 2015·2 cites·16 claims
- 2283US7763590B2Compositions and methods for inhibiting expression of a mutant geneALNYLAM PHARMACEUTICALS INC·Filed 2003·Granted Jul 27, 2010·15 cites·7 claims
- 2382US7700572B2SMAD7 inhibitors for the treatment of CNS diseasesGIULIANI INTERNATIONAL LTD·Filed 2002·Granted Apr 20, 2010·24 cites·4 claims
- 2479US9587240B2Compositions and methods for inhibiting expression of a target geneALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Mar 7, 2017·2 cites·20 claims
- 2576US9074213B2Compositions and methods for inhibiting expression of a target geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Jul 7, 2015·2 cites·15 claims
- 2670US9902955B2Method and medicament for inhibiting the expression of a given geneALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Feb 27, 2018·0 cites·25 claims
- 2770US2018179526A1Method and Medicament For Inhibiting The Expression of A Given GeneALNYLAM PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2868US8729037B2Method and medicament for inhibiting the expression of a given geneKREUTZER ROLAND·Filed 2007·Granted May 20, 2014·0 cites·12 claims
- 2967US9902954B2Method and medicament for inhibiting the expression of a given geneALNYLAM PHARMACEUTICALS INC·Filed 2012·Granted Feb 27, 2018·0 cites·24 claims
- 3064US2011207795A1Smad7 inhibitor compositions and uses thereofSTEINBRECHER ANDREAS·Filed 2009·Application pending·0 cites
- 3157US2013064879A1Compositions and Methods for Inhibiting Viral ReplicationJOHN MATTHIAS·Filed 2012·Application pending·0 cites
- 3257US2004038921A1Composition and method for inhibiting expression of a target geneRIBOPHARMA AG·Filed 2003·Application pending·0 cites
- 3356US2005119202A1Medicament to treat a fibrotic diseaseFiled 2002·Application pending·0 cites
- 3455US2004248835A1Use of a double-stranded ribonucleic acid for treating an infection with a positivestrand rna-virusFiled 2002·Application pending·0 cites
- 3554US2012322858A1Compositions and Methods for Inhibiting Expression of a Mutant GeneKREUTZER ROLAND·Filed 2012·Application pending·0 cites
- 3650US2011065777A1DOUBLE-STRANDED RNA (dsRNA) AND METHOD OF USE FOR INHIBITING EXPRESSION OF A FUSION GENEHEIDENREICH OLAF·Filed 2010·Application pending·0 cites
- 3750US2004126791A1Compositions and methods for treating trail-resistant cancer cellsRIBOPHARMA AG·Filed 2003·Application pending·0 cites
- 3847US2006178324A1Lipophilic derivatives of double-stranded ribonucleic acidHADWIGER PHILIPP·Filed 2004·Application pending·0 cites
- 3946US2008070856A1Medicament to treat a fibrotic diseaseRIBOPHARMA AG·Filed 2007·Application pending·0 cites
- 4042US2010280102A1Double-stranded ribonucleic acid with increased effectiveness in an organismALNYLAM PHARMACEUTICALS·Filed 2010·Application pending·0 cites
- 4138US2004121348A1Compositions and methods for treating pancreatic cancerRIBOPHARMA AG·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan Limmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →